report - apollo laboratoryfinal report date:01/02/16 print date: 01/02/16 print time:10:26 test name...

MARQUIS LABORATORY13301 N. Meridian Ave. #704A, Oklahoma City, OK 73120 Phone: (405)445-6001Fax: (888)972-7527Director: Jim Doe, PhDCLIA#: 0000000000

Client: MEDICAL CLINIC 56123 MAIN ST OKLAHOMA CITY, OK 73159 (405) 555-5555 Fax: (405) 555-5555

Phys: Julie Doe

Age:56 Sex: MPatient: DOE, JOHN DOB. 08/09/1960 Phone: (405) 555-5557 ID#: A1111111111 Route#: 0 Page:1

Accession:1601010002 Chart#Specimen Type:whole blood

Coll. Date:12/31/15 Coll. Time:09:00 AM

Recv. Date: 01/01/16 Recv. Time:09:11 AMFinal report date:01/02/16

Print Date: 01/02/16 Print Time:10:26

Test Name Within Range Out Of Range Ref.Range Units Previous Result (Date)

Report Status: FINAL

HEMATOLOGYCBC WITH AUTO DIFF Tech:MDANE Date:09/21/16 16:08

WBC 5.6 3.6 - 10.2 K/mcL RBC 4.15 4.10 - 5.70 M/mcL HGB 13.9 12.0 - 16.9 g/dL HCT 42.7 36.0 - 49.0 % MCV 103 H 78 - 98 fL MCH 33.5 25.0 - 35.0 pg MCHC 32.6 31.0 - 36.0 % RDW 13.5 11.5 - 16.0 % PLT 246 150 - 400 K/mcL NE 60.4 43.5 - 73.5 % LY 29.9 15.2 - 43.3 % MO 7.4 5.5 - 13.7 % EO 1.7 0.8 - 8.1 % BA 0.6 0.0 - 1.5 % NE (ABSOLUTE) 3.4 1.5 - 8.0 K/mcL LY (ABSOLUTE) 1.7 1.2 - 5.2 K/mcL MO (ABSOLUTE) 0.4 0.2 - 0.9 K/mcL EO (ABSOLUTE) 0.1 0.0 - 0.6 K/mcL BA (ABSOLUTE) 0.0 0.0 - 0.2 K/mcL

CHEMISTRYCOMP METABOLIC PANEL Tech:MCARM Date:09/21/16 19:15

Glucose 96 74 - 109 mg/dL Sodium 134 L 136 - 145 mmol/L Potassium 4.8 3.5 - 5.1 mmol/L Chloride 98 98 - 107 mmol/L Carbon Dioxide (CO2) 22 22 - 29 mmol/L Anion Gap 14 8 - 16 mmol/L Urea Nitrogen 4 L 8 - 23 mg/dL Creatinine 0.60 L 0.67 - 1.17 mg/dL EGFR (NON-AA) 100 Normal > 89 mL/min/m2 EGFR (AA) 116 Normal > 89 mL/min/m2 BUN/Creatinine Ratio 6.7 6.0 - 22.0 Calcium 9.5 8.8 - 10.2 mg/dL Total Protein 7.1 6.0 - 8.3 g/dL Albumin 4.3 3.5 - 5.2 g/dL A/G Ratio 1.5 1.0 - 2.5

(Continued on Next Page)

(L)Low | (H)High | (CL)Critical Low | (CH)Critical High Accession:1601010002 Patient ID:A1111111111 Lab Results For: DOE, JOHN

Originally Reported On:01/02/16 12:11 Page:1 STAT[S] Corrected [C] Added [A]

SAMPLE R

EPORT


CHEMISTRY (Continued)AST (SGOT) 23 0 - 40 IU/mL ALT (SGPT) 14 0 - 41 U/L ALP 79 40 - 129 IU/mL Bilirubin, Total 0.4 0.2 - 1.1 mg/dL Magnesium 1.8 1.6 - 2.4 mg/dL

ADVANCED CARDIO PROFILE Tech:MCARM Date:09/21/16 19:15Cholesterol, Total 231 Borderline High < 200 mg/dL

NCEP ATP Interpretation- Desirable: < 200 mg/dL- Borderline High: 200-239 mg/dL- High: > 239 mg/dL

Pediatric Guidelines (Ages 2-17)- Acceptable: < 170 mg/dL- Borderline High: 170-199 mg/dL- High: > 199 mg/dL

(Pediatrics. 2011; 128:s213)

HDL 51 > 40 mg/dL

NCEP ATP Interpretive Guidelines- Increased Risk: < 40 mg/dL- Average Risk: 40-59 mg/dL- Decreased Risk: > 59 mg/dL

Pediatric Guidelines (Ages 2 - 17)- Low: < 40 mg/dL- Borderline: 40-45 mg/dL- Acceptable: > 45 mg/dL

(Pediatrics. 2011; 128:s213)

LDL (Calculated) 148 Borderline High < 100 mg/dL

NCEP ATP Guidelines- Optimal: < 100 mg/dL- Near Optimal: 100-129 mg/dL- Borderline High: 130-159 mg/dL- High: 160-189 mg/dL- Very High: > 189 mg/dL



Phys: Julie Doe









SAMPLE R

EPORT


CHEMISTRY (Continued)Pediatric Guidelines (Ages 2-17)

- Acceptable: < 110 mg/dL- Borderline High: 110-129 mg/dL- High: > 129 mg/dL

(Pediatrics. 2011; 128:s213)

Triglycerides 159 Borderline High mg/dL CHOL/HDL Ratio 4.5 H < 3.6

CHOL/HDL Risk Ratios- Decreased: < 3.6- Average: 3.6-5.0- Increased: > 5.0

LDL/HDL Ratio 2.9 Optimal

LDL/HDL Risk Ratios- Optimal: < 3.0- Borderline: 3.0-5.9- High: > 5.9

Apolipoprotein A1 156 Optimal > 114 mg/dL Apolipoprotein B 130 High Risk < 80 mg/dL

High Risk (> 119 mg/dL)

APO B/A1 Ratio 0.83 Moderate Risk < 0.70C-Reactive Protein (hs) 2.7 Moderate Risk < 1.0 mg/L

Cardiac Risk Guidelines- Low Risk: < 1.0 mg/L- Moderate Risk: 1.0-3.0 mg/L- High Risk: > 3.0 mg/L

Homocysteine 11 0 - 14.9 mcmol/mL

RBC SEDIMENTATION RATE Tech:MCARM Date:09/21/16 19:29ESR 49 H 0 - 20 mm/hr

Patients with polycythemia and some hemoglobin abnormalities may havedepressed ESR. Patients with anemia may have elevated ESR.




Phys: Julie Doe








SAMPLE R

EPORT


CHEMISTRY (Continued)DIABETIC PROFILE Tech:MCARM Date:09/21/16 19:38

Hemoglobin A1c 5.2 4.0 - 5.6 %

Results may not be representative in presence of non-A variant hemoglobinor conditions that increase RBC turnover.

Estimated Ave Glucose 103 mg/dL Insulin 4.8 2.6 - 24.9 mcU/mL

IRON PROFILE Tech:MCARM Date:09/21/16 21:03Iron 155 59 - 158 mcg/dL TIBC 173 L 250 - 400 mcg/dL UIBC 18 L 112 - 347 mcg/dL Iron Saturation 89.6 H 20 - 55 % Ferritin 1503 H 30 - 400 ng/mL

VITAMIN PROFILE Tech:MCARM Date:09/21/16 18:43Folate 14.5 4.6 - 34.8 ng/mL Vitamin B12 452 211 - 946 pg/mL Vitamin D, 25OH 25 L 30 - 100 ng/mL

THYROID PROFILE Tech:MCARM Date:09/21/16 18:43Thyrotropin (TSH) 2.41 0.27 - 4.20 mcIU/mL T4, Free 1.0 0.9 - 1.7 ng/mL T3, Free 3.2 2.0 - 4.4 pg/mL

THYROID ANTIBODY PROFILE Tech:MCARM Date:09/21/16 18:43Thyroglobulin Ab 12 0 - 115 IU/mL TPO Ab 14 0 - 34 IU/mL

TESTOSTERONE PROFILE Tech:MCARM Date:09/21/16 19:15Testosterone 701 193 - 740 ng/dL SHBG 148 H 19 - 76 nmol/L Testosterone, Free 46 6 - 73 pg/mL Testosterone, Bio 109 15 - 150 ng/dL

HORMONES Tech:MCARM Date:09/21/16 18:43Cortisol (Random) 21.5 H 2.3 - 19.4 mcg/dL Estradiol 18 0 - 49 pg/mL

Due to cross-reactivity within the assay, results on patients treated withfulvestrant may be falsely increased. Alternative methods of measurementshould be requested for any patient being treated with this drug.




Phys: Julie Doe






(L)Low | (H)High | (CL)Critical Low | (CH)Critical High Accession:1601010002 Patient ID:A1111111111Lab Results For: DOE, JOHN




SAMPLE R

EPORT


CHEMISTRY (Continued)FSH 52.8 H 1.5 - 12.4 IU/mL Luteinizing Hormone (LH) 25.7 H 1.7 - 8.6 IU/mL DHEA-Sulfate 144 34 - 249 mcg/dL

PROSTATE SPECIFIC AG Tech:MCARM Date:09/21/16 18:43PSA, Total 3.64 <6.23 pg/mL

Reference intervals based on cohort study of apparently healthy males.Typical PSA Cutoff Value: 4.00 ng/mL

Reference intervals not established for patients under 18 years of age.

URINALYSIS Tech:MDANE Date:09/21/16 12:11COLOR YELLOWAPPEARANCE CLEARpH 6.5 4.5 - 8.5 Specific Gravity 1.015 1.001 - 1.035 GLUCOSE NEG 0 - 500 mg/dL KETONES NEG NEGATIVEBILIRUBIN NEG NEGATIVEUROBILINOGEN 0.2 0.0 - 1.0 mg/dL PROTEIN NEG NEGATIVENITRITE NEG NEGATIVELEUKOCYTES NEG NEGATIVEURINE BLOOD NEG NEGATIVE

_______________ END OF REPORT _______________



Phys: Julie Doe








SAMPLE R

EPORT


Client: MEDICAL CLINIC 56123 Main StreetOklahoma City, OK 73159(405) 555-5555 Fax: (405) 555-5556

Phys: Julie Doe


Accession:1601010001 Chart#

Coll. Date:12/31/15 Coll. Time:



Specimen Type: Urine

Prescribed Medications: Mobic, Norco (Hydrocodone)

SPECIMEN VALIDITY TESTING TEST RESULTS FLAG EXPECTED RESULTS TEST RESULTS FLAG EXPECTED RESULTS

pH 5.3 NORMAL 5.0 - 9.0 Specific Gravity 1.028 ABNORMAL 1.01 - 1.025 Oxidants 0 NORMAL 200 mg/L Creatinine 191 NORMAL 80 - 200 mg/dL

IMMUNOASSAY SCREENINGDRUG RESULTS CUTOFF DRUG RESULTS CUTOFF

Amphetamines Negative 1000 ng/mL Barbiturates Negative 200 ng/mL Benzodiazepines Negative 200 ng/mL Buprenorphine Negative 10 ng/mL Cocaine Metabolite Negative 300 ng/mL Methadone Metabolite Negative 1000 ng/mL Methadone Negative 300 ng/mL Phencyclidine Negative 25 ng/mL Tricyclic Antidepressants Negative 500 ng/mL Cannabinoids Negative 50 ng/mL Opiates Positive 300 ng/mL Oxycodone Negative 100 ng/mL Ethyl Glucuronide Negative 500 ng/mL Synthetic Cannabinoids Negative 100 ng/mL Tramadol Negative 200 ng/mL Ecstasy Negative 500 ng/mL

6-Acetylmorphine Negative 10 ng/mL

_______________ END OF REPORT _______________

The results given are for clinical diagnostic purposes only. Marquis Labs is regulated and qualified under CLIA to perform high-complexity testing.

MARQUIS LABORATORY (405)225-2280 Page 1

SAMPLE R

EPORT

report - apollo laboratoryfinal report date:01/02/16 print date: 01/02/16 print time:10:26 test name...

Documents